PathGroup will operate normal business hours on Good Friday (April 19, 2019) and Easter Monday (April 22, 2019). There will be no disruption in services during this time.
For further questions, please contact PathGroup Client Services at 1-888-474-5227
Sexually transmitted infections (STIs) are viruses or bacteria spread through sexual contact with an infected individual. Some of the most common STIs are: chlamydia, gonorrhea, trichomonas vaginalis, and mycoplasma genitalium (M. gen). An estimated 20 million new STIs occur every year in the United States.
To learn more, click here.
Colorectal cancer is the third most common cancer in the United States. There are an estimated 140,000 new cases diagnosed every year and about 50,000 people lose their lives to colorectal cancer each year. According to the American Cancer Society, the risk of developing colorectal cancer is slightly lower in women (4.15%) than in men (4.49%).
Click here for more information about Colorectal Cancer Awareness Month.
PathGroup recognizes the efforts of the American Heart Association and healthcare providers in identifying, diagnosing and managing patients at risk for and impacted by heart disease.
Click here for more information about American Heart Month.
BALTIMORE – (Monday, January 7, 2019) – Personal Genome Diagnostics Inc. (PGDx), a leader in cancer genomics, and PathGroup, a premier provider of anatomic, clinical and molecular laboratory services, announced today that they have entered into a co-development agreement for the PGDx elio™ tissue complete assay.
Click Here to read the press release.
Brentwood, TN – (Monday, November 12, 2018) Dr. Kathryn Knight, Medical Director for Women’s Health Services and Cytopathology for PathGroup Laboratories, was elected Speaker of the House of Delegates at the recent annual meeting of the College of American Pathologists in Chicago, Illinois.
Click here to read the entire press release.
After serving as President-Elect/Scientific Program Chair for the annual meeting held in Denver, CO in 2017, Alan Lennon, PhD, FACMG took the helm as President of the Cancer Genomics Consortium. The Cancer Genomics Consortium (CGC) is a non-profit organization formed in 2009 by a group of clinical cytogeneticists, molecular geneticists, and molecular pathologists who are interested in applying whole genome and other genetic technologies to cancer diagnosis and cancer research. During his presidential term, working groups which Lennon fostered back in 2016 to publish evidence-based reviews on assessing whole genome copy number aberrations and copy neutral loss of heterozygosity as best practice in a variety of cancers saw several works accepted for publication. Over 270 cancer geneticists from 7 countries converged on the annual meeting in Nashville, TN, August 5 – 8. The 2018 Annual Meeting was the largest meeting to date and was supported by the largest corporate sponsorship to date. Lennon’s presidential term culminated at the annual meeting, although he serves two more years on the Board of Directors.
Brentwood, TN – (Wednesday, March 7, 2018) – PathGroup, a premier provider of anatomic, clinical and molecular pathology laboratory services, is pleased to announce that Christopher Coldren, PhD has co-authored an evidence based guideline published in the Journal of Molecular Diagnostics (Nov. 2017) entitled “Standards and Guidelines for Validating Next-Generation Sequencing Bioinformatics Pipelines.”
To read the full release, CLICK HERE
Brentwood, TN – (Tuesday, November 7, 2017) – PathGroup, one of the largest private providers of pathology and laboratory services in the Unites States, is pleased to announce that Malini Sathanoori, PhD has been selected to serve on the Editorial Board for the journal Cancer Genetics.
To see the full release, CLICK HERE
Brentwood, TN – (Thursday, October 12, 2017) – PathGroup, one of the largest private providers of pathology and laboratory services in the Unites States, is pleased to announce that that Dr. Pranil K. Chandra will present at the 9th Annual Personalized and Precision Medicine Conference held October 16 – 17, 2017 in Orlando, Florida. Dr. Chandra currently serves as Vice President and Chief Medical Officer of Genomic and Clinical Pathology.
To see the full release, please CLICK HERE